ORPHA:525731
Pediatric-onset Graves disease
Also known as: Pediatric-onset Basedow disease
Publications
0
Trials
0
Interventional, condition-specific
Researchers
0
Distinct authors in sample
Gene link
—
Readiness
0/6
Stages with a signal
Clinical definition (Orphanet)
A rare endocrine disease characterized by the presence of serum autoantibodies against thyroid-stimulating hormone receptors, leading to increased thyroid hormone production and secretion, causing diffuse toxic goiter. Patients present in childhood with signs of thyrotoxicosis (such as tachycardia, weight loss, hand tremor, and sweating), diffuse enlargement of the thyroid gland, and orbitopathy. Additional signs and symptoms include decreased academic and athletic performance, accelerated growth, restlessness, fatigue, sensitivity to heat, and amenorrhea, among others.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0033925
- UMLS:C5680179
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
0/6 stages with a signal
Search queries returned nothing — this usually means a naming mismatch, not proof that nothing exists.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteratureNot checked
Query returned nothing — not evidence of absence Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot checked
Broken query — trial zero not trusted
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
0
We found no papers under this exact name — work may still exist under another label.
0 in the last 10 years · low confidence
Phrase hits: 0 · MeSH hits: 0
Who's working on it?
0
Distinct author names in 0 sampled papers.
Who's working on it?
No author names could be extracted from the sampled publications. Try the Europe PMC query in “How we counted this,” or contact an umbrella rare-disease organisation for researcher referrals.
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 83 trials are registered for Graves disease, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
low confidence
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
83 interventional trials matched Graves disease, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: Graves disease
83
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT03517579·RECRUITING·Personalized Treatment in Thyroid Disorders
Conditions: Thyroid Cancer · Graves Disease·Matched via name phrase
- NCT07261345·RECRUITING·Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease
Conditions: Graves' Disease·Matched via name phrase
- NCT06134219·RECRUITING·Course for Brain Fatigue After Graves' Disease Controlled Study
Conditions: Graves Disease·Matched via name phrase
- NCT07682896·RECRUITING·Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Conditions: Graves' Disease·Matched via name phrase
- NCT07018323·RECRUITING·A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Conditions: Graves' Disease·Matched via name phrase
- NCT06540469·NOT YET RECRUITING·Iodine Supplementation in Graves' Hyperthyroidism
Conditions: Graves Disease · Hyperthyroidism·Matched via name phrase
- NCT05461820·RECRUITING·Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
Conditions: Graves Disease · Relapse · Treatment · Drug Withdrawal·Matched via name phrase
- NCT07333677·RECRUITING·In Vivo CAR-T for Refractory Graves' Disease
Conditions: Graves' Disease·Matched via name phrase
- NCT06327828·NOT YET RECRUITING·Methimazole in Graves' Disease - Comparing the Computer-aided Treatment DigiThy Versus Usual Care
Conditions: Graves Disease·Matched via name phrase
- NCT06068179·RECRUITING·Graves' Disease Remission Study: MycoMeth Combo
Conditions: Graves' Disease·Matched via name phrase
- NCT07369063·RECRUITING·Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease
Conditions: Graves Disease · Graves' Disease · Hyperthyroidism·Matched via name phrase
- NCT07596849·RECRUITING·A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
Conditions: Graves Disease·Matched via name phrase
- NCT06727604·RECRUITING·A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Conditions: Graves' Disease·Matched via name phrase
- NCT07286656·RECRUITING·A Study of GensSci098 in Subjects With Graves' Disease
Conditions: Safety · Tolerability · GenSci098 · Graves Disease·Matched via name phrase
- NCT07570316·RECRUITING·A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
Conditions: Graves' Disease · Graves Disease·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Pediatric-onset Graves disease" OR "Pediatric-onset Basedow disease"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Pediatric-onset Graves disease" OR "Pediatric-onset Basedow disease"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"Graves disease"
Query health: broken — strategies attempted: phrase; with hits: none
Parent literature probe: Graves disease (MONDO:0005364) — 38148 hits
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Zero publications but parent term Graves disease has 38148 — literature likely indexed under a broader name
Ingested 2026-07-27T18:03:55.854Z · excluded from neglect metrics
